Kuwahara T, Hamada M, Hiwada K
The Second Department of Internal Medicine, Ehime University School of Medicine, Japan.
J Nucl Med. 1998 Sep;39(9):1486-91.
Increased sympathetic nervous activity has been proposed as one of the causes of left ventricular hypertrophy (LVH) associated with hypertension. However, the precise relationship is not fully understood.
To elucidate the relationship between myocardial sympathetic nervous activity and LVH in patients with essential hypertension EHT), we performed 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy in 49 patients with EHT and 17 normotensive control subjects. Sympathetic innervation of the left ventricle was evaluated using SPECT, and the whole heart uptake of the tracer was quantitatively assessed as the heart-to-mediastinum uptake ratio on both the early (15-min) and delayed (5-hr) images. Myocardial washout rate (MWR) of the tracer from 15 min to 5 hr after the isotope administration was also calculated. The left ventricular mass index (LVMI) was determined echocardiographically.
In 49 hypertensive patients, there was a negative correlation between LVMI and heart-to-mediastinum uptake ratio on both the early and delayed images (r=-0.55, p < 0.0001; r=-0.63, p < 0.0001, respectively). In addition, there was a positive correlation between the LVMI and MWR of 123I-MIBG in these hypertensive patients (r=0.59, p < 0.0001). As for the regional uptake of the tracer, there was no significant difference between control subjects and hypertensive patients without cardiac hypertrophy, but a significant decrease of the uptake in the inferior and lateral regions was observed in hypertensive patients with cardiac hypertrophy.
Patients with EHT had decreased accumulation and increased MWR of 123I-MIBG in proportion to the degree of LVH. Hypertensive patients with cardiac hypertrophy had impaired sympathetic innervation in the inferior and lateral regions of the left ventricle.
交感神经活动增强被认为是高血压相关左心室肥厚(LVH)的病因之一。然而,确切关系尚未完全明确。
为阐明原发性高血压(EHT)患者心肌交感神经活动与LVH之间的关系,我们对49例EHT患者和17例血压正常的对照者进行了123I-间碘苄胍(MIBG)心肌闪烁显像。使用单光子发射计算机断层扫描(SPECT)评估左心室的交感神经支配情况,并在早期(15分钟)和延迟(5小时)图像上定量评估示踪剂的全心摄取,以心/纵隔摄取比值表示。还计算了同位素给药后15分钟至5小时示踪剂的心肌清除率(MWR)。通过超声心动图测定左心室质量指数(LVMI)。
在49例高血压患者中,LVMI与早期和延迟图像上心/纵隔摄取比值均呈负相关(分别为r = -0.55,p < 0.0001;r = -0.63,p < 0.0001)。此外,这些高血压患者的LVMI与123I-MIBG的MWR呈正相关(r = 0.59,p < 0.0001)。关于示踪剂的局部摄取,对照者与无心脏肥厚的高血压患者之间无显著差异,但在有心脏肥厚的高血压患者中,下壁和侧壁区域的摄取显著降低。
EHT患者123I-MIBG的蓄积减少且MWR增加,与LVH程度成比例。有心脏肥厚的高血压患者左心室下壁和侧壁区域的交感神经支配受损。